rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Sujay Kango

Director

Company insider

Files Form 4 as: Director, Dianthus Therapeutics; Director, Lite Strategy; Chief Commercial Officer, Infinity Pharmaceuticals; EVP, Chief Commercial Officer, Acceleron Pharma.

Every Form 4 they filed

In numbers

Trades disclosed
50
Buys
0
Sells
8
Bought
$0
Sold
$3.7M
Companies
4
Companies where not an officer
2
First trade
31 Mar 2015
Last trade
21 May 2026
Last filed
22 May 2026

Companies traded

Where they are an officer
Infinity PharmaceuticalsDirector, Officer · last 30 Mar 20220 buys · 2 sells
Acceleron PharmaOfficer · last 19 Nov 20210 buys · 6 sells
Everywhere else they filed: board seats, 10% stakes, other companies
DNTH Dianthus TherapeuticsDirector · Biotechnology · last 21 May 20260 buys · 0 sells
LITS Lite StrategyDirector · Biotechnology · last 29 Sep 20230 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
21 May 2026filed 22 May 2026DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,090 at $0.00filing
21 May 2026filed 22 May 2026DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—6,090 at $0.00filing
4 Mar 2025filed 5 Mar 2025DNTH Dianthus Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—25,000 at $0.00filing
29 Sep 2023filed 12 Oct 2023LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
5 Jul 2022filed 7 Jul 2022LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—87,500 at $0.00filing
30 Mar 2022filed 31 Mar 2022Infinity Pharmaceuticalsoption or derivativeSEC FORM 4 Code A—90,000 at $0.00filing
22 Nov 2021filed 23 Nov 2021LITS Lite Strategyoption or derivative · BiotechnologySEC FORM 4 Code A—58,334 at $0.00filing
19 Nov 2021filed 22 Nov 2021Acceleron Pharmaoption or derivativeSEC FORM 4 Code D—25,000filing
19 Nov 2021filed 22 Nov 2021Acceleron Pharmaoption or derivativeSEC FORM 4 Code D—25,500filing
19 Nov 2021filed 22 Nov 2021Acceleron Pharmaoption or derivativeSEC FORM 4 Code D—24,334filing
19 Nov 2021filed 22 Nov 2021Acceleron Pharmaoption or derivativeSEC FORM 4 Code D—20,896filing
19 Nov 2021filed 22 Nov 2021Acceleron PharmaSEC FORM 4 Code U—18,509filing
27 Sep 2021filed 27 Sep 2021Acceleron Pharmaoption or derivativeSEC FORM 4 Code M—5,000 at $0.00filing
27 Sep 2021filed 27 Sep 2021Acceleron PharmaSEC FORM 4 Code M$203K5,000 at $40.61filing
27 Sep 2021filed 27 Sep 2021Acceleron PharmaSEC FORM 4 Sold$875K5,000 at $175.00filing
21 Sep 2021filed 22 Sep 2021Acceleron Pharmaoption or derivativeSEC FORM 4 Code M—5,000 at $0.00filing
21 Sep 2021filed 22 Sep 2021Acceleron PharmaSEC FORM 4 Code M$203K5,000 at $40.61filing
21 Sep 2021filed 22 Sep 2021Acceleron PharmaSEC FORM 4 Sold$750K5,000 at $150.03filing
2 Mar 2021filed 4 Mar 2021Acceleron PharmaSEC FORM 4 Code M$203K5,000 at $40.61filing
2 Mar 2021filed 4 Mar 2021Acceleron PharmaSEC FORM 4 Sold$366K2,699 at $135.48filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed8

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.